Calithera Biosciences, Inc.
Heterocyclic glutaminase inhibitors

Last updated:

Abstract:

The invention relates to novel heterocyclic compounds and pharmaceutical preparations thereof. The invention further relates to methods of treatment using the novel heterocyclic compounds of the invention.

Status:
Grant
Type:

Utility

Filling date:

15 Nov 2013

Issue date:

6 Oct 2020